National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$61.50
add to cart

Rights & Permissions

topleft topright

Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment (2007)
Board on Environmental Studies and Toxicology (BEST)
Board on Life Sciences (BLS)

Citation Manager

. "11 Ethical, Legal, and Social Issues." Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment. Washington, DC: The National Academies Press, 2007.

Please select a format:

BibTeX EndNote RefMan


Page
200
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Applications of Toxicogenomic Technologies to Predictive Toxicology and Risk Assessment
  1. Educational initiatives are needed for vulnerable subgroups and the general public to raise awareness about toxicogenomic findings that can affect their health.

  2. Educational initiatives need to be developed and implemented to prepare the medical and public health workforce to use toxicogenomic information.

Finally, several areas of future research would address some of the issues raised in this chapter. These include the following:

  1. Federal agencies should increase their support for research on the issues of ethical, legal, and social implications in applying toxicogenomic technologies, including public attitudes toward individualized risk, social effects of personalized information on increased risks, and regulatory criteria for toxicogenomics.

  2. The National Institute of Environmental Health Sciences (or other federal agencies) should develop “points-to-consider” documents that identify and discuss the issues of ethical, legal, and social implications relevant to individual researchers, institutional review boards, research institutes, companies, and funding agencies participating in toxicogenomic research and applications.

Page
200